Cancer Research AACR Legacy  Jordan
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 50, 6615-6619, October 15, 1990]
© 1990 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tanaka, H.
Right arrow Articles by Tokiwa, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tanaka, H.
Right arrow Articles by Tokiwa, T.

Influence of Renal and Hepatic Failure on the Pharmacokinetics of Recombinant Human Granulocyte Colony-stimulating Factor (KRN8601) in the Rat

Hideji Tanaka1 and Tomonobu Tokiwa

Pharmaceutical Development Laboratory, Kirin Brewery Co., Ltd., 2-2, Souja-machi I-chome, Maebashi-shi, Gunma 371, Japan

The pharmacokinetics of recombinant human granulocyte colony-stimulating factor (rhG-CSF) was studied in rats experiencing renal and hepatic failure. The serum concentration of rhG-CSF after i.v. administration to male Sprague-Dawley rats at a dose of 10 µg/kg was investigated by a sandwich enzyme immunoassay. Total-body clearance of rhG-CSF was 44.48 ml/h/kg in sham-operated rats compared with 9.429 ml/h/kg in bilaterally nephrectomized rats. In sham-operated rats, the half-life (ß) of rhG-CSF was 1.512 h, and it increased to 5.333 h after nephrectomy. The volumes of distribution were identical in both rats. In rats with acute renal failure induced by uranyl nitrate, the clearance and volume of distribution were identical to those of control rats, but the half-life (ß) was slightly shorter. In partially (70%) hepatectomized rats, the clearance of rhG-CSF decreased from 42.08 ml/h/kg to 31.93 ml/h/kg. Similar half-lives were observed in rats in both the sham-operated and hepatectomized groups. However, the volume of distribution decreased after hepatectomy. In rats with hepatic failure induced by CCL4, the pharmacokinetic changes were similar to those observed in hepatectomized rats. These results suggest that renal clearance makes a major contribution to total-body clearance compared with hepatic clearance.

1 To whom requests for reprints should be addressed.

Received 5/11/90. Accepted 7/13/90.




This article has been cited by other articles:


Home page
J Clin PharmacolHome page
B.-B. Yang, A. Kido, M. Salfi, S. Swan, and J. T. Sullivan
Pharmacokinetics and Pharmacodynamics of Pegfilgrastim in Subjects With Various Degrees of Renal Function
J. Clin. Pharmacol., September 1, 2008; 48(9): 1025 - 1031.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
T. S. Hoke, I. S. Douglas, C. L. Klein, Z. He, W. Fang, J. M. Thurman, Y. Tao, B. Dursun, N. F. Voelkel, C. L. Edelstein, et al.
Acute Renal Failure after Bilateral Nephrectomy Is Associated with Cytokine-Mediated Pulmonary Injury
J. Am. Soc. Nephrol., January 1, 2007; 18(1): 155 - 164.
[Abstract] [Full Text] [PDF]


Home page
Antimicrob. Agents Chemother.Home page
S. Walsh, A. Shah, and J. Mond
Improved Pharmacokinetics and Reduced Antibody Reactivity of Lysostaphin Conjugated to Polyethylene Glycol
Antimicrob. Agents Chemother., February 1, 2003; 47(2): 554 - 558.
[Abstract] [Full Text] [PDF]


Home page
Antimicrob. Agents Chemother.Home page
M. Fukuda, M. Oka, Y. Ishida, H. Kinoshita, K. Terashi, M. Fukuda, S. Kawabata, A. Kinoshita, H. Soda, and S. Kohno
Effects of Renal Function on Pharmacokinetics of Recombinant Human Granulocyte Colony-Stimulating Factor in Lung Cancer Patients
Antimicrob. Agents Chemother., July 1, 2001; 45(7): 1947 - 1951.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
S. Tsunoda, T. Ishikawa, Y. Yamamoto, H. Kamada, K. Koizumi, J. Matsui, Y. Tsutsumi, T. Hirano, and T. Mayumi
Enhanced Antitumor Potency of Polyethylene Glycolylated Tumor Necrosis Factor-alpha : A Novel Polymer-Conjugation Technique with a Reversible Amino-Protective Reagent
J. Pharmacol. Exp. Ther., July 1, 1999; 290(1): 368 - 372.
[Abstract] [Full Text]


Home page
Antimicrob. Agents Chemother.Home page
K. Terashi, M. Oka, S. Ohdo, T. Furukubo, C. Ikeda, M. Fukuda, H. Soda, S. Higuchi, and S. Kohno
Close Association between Clearance of Recombinant Human Granulocyte Colony-Stimulating Factor (G-CSF) and G-CSF Receptor on Neutrophils in Cancer Patients
Antimicrob. Agents Chemother., January 1, 1999; 43(1): 21 - 24.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1990 by the American Association for Cancer Research.